Literature DB >> 21840119

Identifying risk factors in patients with non-muscle-invasive bladder cancer: clinical implications.

Bernd J Schmitz-Dräger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21840119     DOI： 10.1016/j.eururo.2011.07.065

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  8 in total

1.  Association between glutathione S-transferase M1 null variant and risk of bladder cancer in Chinese Han population.

Authors:  Wei Xu; Fa Wang; Li Ying; Hong-Hui Wang
Journal:  Tumour Biol       Date:  2014-01

2.  Body mass and smoking are modifiable risk factors for recurrent bladder cancer.

Authors:  Asaf Wyszynski; Sam A Tanyos; Judy R Rees; Carmen J Marsit; Karl T Kelsey; Alan R Schned; Eben M Pendleton; Maria O Celaya; Michael S Zens; Margaret R Karagas; Angeline S Andrew
Journal:  Cancer       Date:  2013-10-10       Impact factor: 6.860

3.  Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence.

Authors:  Angeline S Andrew; Carmen J Marsit; Alan R Schned; John D Seigne; Karl T Kelsey; Jason H Moore; Laurent Perreard; Margaret R Karagas; Lorenzo F Sempere
Journal:  Int J Cancer       Date:  2015-02-25       Impact factor: 7.396

4.  MicroRNA Dysregulation and Non-Muscle-Invasive Bladder Cancer Prognosis.

Authors:  Angeline S Andrew; Margaret R Karagas; Florian R Schroeck; Carmen J Marsit; Alan R Schned; Jason R Pettus; David A Armstrong; John D Seigne
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-30       Impact factor: 4.254

5.  Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer.

Authors:  Hui Zhang; Xiuhua Wen; Xueren Lu; Hui Zhang
Journal:  Tumour Biol       Date:  2013-07-20

6.  Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study.

Authors:  Angeline S Andrew; Jiang Gui; Ting Hu; Asaf Wyszynski; Carmen J Marsit; Karl T Kelsey; Alan R Schned; Sam A Tanyos; Eben M Pendleton; Rebecca M Ekstrom; Zhongze Li; Michael S Zens; Mark Borsuk; Jason H Moore; Margaret R Karagas
Journal:  BJU Int       Date:  2014-03-26       Impact factor: 5.588

7.  The MMP-1, MMP-2, and MMP-9 gene polymorphisms and susceptibility to bladder cancer: a meta-analysis.

Authors:  Yulan Yan; Hongjie Liang; Taijie Li; Meng Li; Ruolin Li; Xue Qin; Shan Li
Journal:  Tumour Biol       Date:  2014-01-05

8.  Definitive BCG immunotherapy versus radical cystectomy in intermediate or high-risk nonmuscle invasive bladder cancer patients: A retrospective study.

Authors:  Xiaoming Jian; Mingkang Shen; Guodong Liao
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.